Published on
March 10, 2026
- 11:00 GMT
dGenThera and Alpha Nuclide Announce Strategic Astatine-211 (At-211) Partnership for Radiopharmaceutical R&D in China
dGenThera, Inc., a radiopharmaceutical company, announces partnership with Alpha Nuclide Co, LTD to secure scalable supply of Astatine-211 (At-211) in China. DURHAM, NC, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- [DURHAM, NC, USA and JIAXING, …
Distribution channels:
Chemical Industry, Companies
...
